Screening for ATTR heart amyloid in older HFpEF patients
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study looks at how often a specific heart condition (ATTR amyloid) occurs in people age 65+ who have HFpEF. It also tries to predict who might have it, using a special heart scan, and may help your care team identify it earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of HFpEF (heart failure with preserved pumping strength)
- You are 65 years old or older
- Your kidneys are not in the very advanced stage that requires dialysis (eGFR under 15)
- You have not had a negative 99mTc-pyrophosphate heart scan within the last year
- You can lie flat and stay still for 15 minutes during the scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from adults who have been diagnosed with, or are being checked for, ATTR amyloidosis (a condition where abnormal protein builds up in the body) using a heart PYP scan. Your participation may help doctors better understand how these scans relate to diagnosis and follow-up over time.
This study looks at past bone scans to find signs of a heart condition called amyloidosis, where abnormal proteins build up in the heart. It may help identify more people with this condition and improve future diagnosis.
This research study checks a small sample of heart tissue during pacemaker or defibrillator placement to see if amyloidosis, a condition where abnormal proteins build up in organs, is present. It aims to find amyloidosis earlier so treatment can start sooner.
This study tests a new PET imaging agent (evuzamitide) to see if it can better detect cardiac amyloidosis when earlier tests were unclear. It may help confirm if the heart problem is related to TTR amyloid and guide further care.
This study uses a special ultrasound to measure heart stiffness in people 60 and older who have heart failure with preserved or mildly reduced pumping function, with or without a condition called ATTR amyloidosis (a protein buildup in the heart). It also includes healthy controls.
This study tests a new type of imaging scan ([64Cu]FBP8 PET) to detect blood clots that may form in the heart's left atrial appendage (a small pouch in the heart) in patients with amyloid cardiomyopathy (a disease where abnormal protein builds up in heart muscle) who also have irregular heartbeat. The scan may help doctors catch clots earlier and prevent strokes.
Hear when a new Transthyretin Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.